Inhibition of lung adenocarcinoma transfected with interleukin 28a recombinant adenovirus (Ad-mIFN-λ2) in vivo

Cancer Biotherapy and Radiopharmaceuticals

Volumn 28, Issue 2, 2013, Pages 124-130

  Yan, Yulan ^a   Zhang, Jin ^a   Liu, Yang ^a   Zhu, Taofeng ^b   Yuan, Lixue ^c   Ge, Yuxi ^d   Ding, Hao ^a   Bu, Xuefeng ^a  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b People's Hospital of Yixing   (China)

^c Huang shi Institute of Technology   (China)

^d Department of Diagnostic Imaging   (China)

Author keywords

apoptosis; immune response; in vivo; lung cancer; mIFN 2

Indexed keywords

ADENOVIRUS VECTOR; CD3 ANTIGEN; CD4 ANTIGEN; CD49 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 28A; LYMPHOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER GROWTH; CANCER INHIBITION; CARCINOMA CELL; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSFECTION; GROWTH INHIBITION; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VIVO STUDY; LUNG ADENOCARCINOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR IMMUNITY; TUMOR NECROSIS; VIRAL GENE DELIVERY SYSTEM;

ADENOCARCINOMA; ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CYTOKINES; FLOW CYTOMETRY; GENETIC THERAPY; GENETIC VECTORS; LUNG NEOPLASMS; MICE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 84874725234     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1247     Document Type: Article

References (19)

1. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;1:8.
2. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997;6:1710.
3. Spiro SG, Silvestri GA. One hundred years of lung cancer. Am J Respir Crit Care Med 2005;5:523.
4. Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex. Nat Immunol 2003;4:69.
5. Sheppard P, Kindsvogel W, Xu WF, et al. IL-28,IL-29 and their class II cytokine receptor IL-28R. Nat Immunol 2003;4:63.
6. Meager A, Visvalingam K, Dilger P, et al. Biological activity of interleukins-28 and-29:comparison with type I interferons. Cytokine 2005;31:109.
7. Dumoutier L, Tounsi A, Michiels T, et al. Role of the interleukin (IL)-28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1: Similarities with type I interferon signaling. Biol Chem 2004;279:32269.
8. Sato A, Ohtsuki M, Hata M, et al. Antitumor activity of IFN-lambda in murine tumor models. Immunol 2006;176: 7686.
9. Numasaki M, Tagawa M, Iwata F, et al. IL-28 elicits antitumor responses against murine fibrosarcoma. Immunol 2007;178:5086.
10. Halter R. Strategies to express factor VIII gene constructs in the ovine mammary gland. Theriogenology 1993;39:137.
11. Onoguchi K, Yoneyama M, Takemura A, et al. Viral infections activate types I and III interferon genes through a common mechanism. J Biol Chem 2007;282:7576.
12. Ank N, West H, Bartholdy C, et al. Lambda interferon(IFNlambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo. J Virol 2006;80:4501.
13. Li J, Ye L, Wang X, et al. Induction of interferon-k contributes to toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes. J Neurosci Res 2011;90:399.
14. Miller DM, Klucher KM, Freeman JA, et al. Interferon lambda as a potential new therapeutic for hepatitis C. Ann N Y Acad Sci 2009;1182:80.
15. Pagliaccetti NE, Chu EN, Bolen CR, et al. Lambda and alpha interferons inhibit hepatitis B virus replication through a common molecular mechanism but with different in vivo activities. Virology 2010;401:197.
16. Brand S, Beigel F, Olszak T, et al. IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression. Am J Physiol Gastrointest Liver Physiol 2005; 289:G960.
17. Lasfar A, Lewis-Antes A, Smirnov SV, et al. Characterization of the mouse IFN-lambda ligand-receptor system: IFNlambdas exhibit antitumor activity against B16 melanoma. Cancer Res 2006;66:4468.
18. Tian H, Ming-cai L, Ming-yao W, et al. Association between IL.29 expression and clinical and pathological features in esophageal carcinoma. Guangdong Med J 2009; 30:204.
19. O'Neill LAJ. Toll-like receptor signal transduction and the tailoring of innate immunity: A role for Mal? Trends Immunol 2002;23:296.